ESMO 2012 Congress Audio Interviews

Journalist Adam Kirtley talks to the ESMO 2012 press officer, Fortunato Ciardiello, about his hopes for new treatments, their cost effectiveness and the prospects of finding solutions to the likes of pancreatic cancer.

Personalised medicine is looking not only at the individual type of cancer, but how it is affecting the individual person that has the disease. By selecting certain patients for certain types of treatment, not only is the outcome for that patient likely to be better, but treatment that would be useless can be avoided, saving unnecessary side-effects and money. Journalist Adam Kirtley interviews Josep Tabernero, ESMO 2012 Scientific Chair.

This is something that oncologists at ESMO 2012 have been discussing. Nathan Cherny talks to journalist Adam Kirtley about a worldwide study looking into the problem, and potential solutions.

The study looked not only at the direct healthcare costs, such as hospitalisation, drugs etc. but also at the burden of days lost, both by the patients and their carers. Dr. Ramon Luengo-Fernandez, an economist who worked on the study, talks to journalist Adam Kirtley about what exactly the study consisted of and what lessons might be learnt.

Cristiana Sessa, a medical oncologist in Switzerland, speaks to journalist Adam Kirtley at the ESMO 2012 Congress in Vienna about where oncologists are in their quest to find solutions, and told him about some exciting news being revealed in Vienna.

Dr. Derek Power talks to journalist Adam Kirtley about the results of a study being released at ESMO 2012 in Vienna.

Educating oncologists and patients alike can help better diagnosis and care of cancer, let alone prevention, as discussed at ESMO 2012 within the general remit of "personalised care".

Vienna sees the ESMO congress look at how cancer treatment is moving forward.